Brought to you by 
Guidant licenses rights to Micro Therapeutics technologies
04 Oct 2001
Executive Summary
Guidant has agreed to invest up to $10mm in Micro Therapeutics' (devices for vascular disease) in the form of convertible debt, equity, and a credit line, in exchange for exclusive European rights to MT's Embolyx neurovascular technologies.
Deal Industry
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Surgical Equipment & Devices
Deal Status
- Terminated
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Guidant licenses rights to Micro Therapeutics technologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice